TCG Crossover
Overview
TCGX is a registered investment advisor based in Palo Alto, California. TCGX invests in both private and public opportunities, focusing on innovative pre-IPO and public drug discovery companies. We in…
Investment Focus
- Focus on innovative biotech companies
- Preference for companies with transformative medicines
- Interest in both private and public companies
- Global investment scope including North America, Europe, and China
- Long-term partnership approach with patient capital
Portfolio Companies
Reach TCG Crossover directly
Verified work email, phone and LinkedIn for the full team — one spreadsheet, one payment, yours to keep.
Unlock full contacts →Frequently asked questions about TCG Crossover
What sectors does TCG Crossover invest in?
TCG Crossover invests in Healthcare, Digital Health, Pharmaceuticals, Medical Devices, Diagnostics and Biotechnology, and is based in Palo Alto, United States. TCG Crossover is listed as a venture capital in the ConnectSafely investor database.
What stage does TCG Crossover invest at?
TCG Crossover backs companies at Seed, Early Stage, Series A, Series B, Growth and Late Stage, writing cheques of 10M - 500M.
Which regions does TCG Crossover invest in?
TCG Crossover invests across United States, Europe and China.
Who are the partners at TCG Crossover?
Team members listed for TCG Crossover include Craig Skaling (Chief Operating Officer/ Chief Financial Officer) and Giuliano Marostica (Managing Partner).
What companies has TCG Crossover invested in?
TCG Crossover's portfolio includes Adcendo, COMPASS Pathways, Obsidian Therapeutics, Arbor Biotechnologies, Aviceda Therapeutics, Vicebio, Candid Therapeutics and Pathalys Pharma.
How do I contact TCG Crossover?
TCG Crossover's contact details — including phone and LinkedIn — are listed in the ConnectSafely investor database, along with its website and the LinkedIn profiles of its partners.
Last updated · Source: ConnectSafely investor database
